Plants rely on concentration gradients of the native auxin, indole-3-acetic acid (IAA), to modulate plant growth and development. Both metabolic and transport processes participate in the dynamic regulation of IAA homeostasis. Free IAA levels can be reduced by inactivation mechanisms, such as conjugation and degradation. IAA can be conjugated via ester linkage to glucose, or via amide linkage to amino acids, and degraded via oxidation. Members of the UDP glucosyl transferase (UGT) family catalyze the conversion of IAA to indole-3-acetyl-1glucosyl ester (IAGlc); by contrast, IAA is irreversibly converted to indole-3acetyl-L-aspartic acid (IAAsp) and indole-3-acetyl glutamic acid (IAGlu) by Group II of the GRETCHEN HAGEN3 (GH3) family of acyl amido synthetases.
Several regulatory mechanisms operate in plant cells to modulate the levels of the bioactive form of this hormone [5] .
The major active auxin found in plants is indole-3-acetic acid (IAA). IAA is synthesized in plants primarily by the tryptophan (Trp)-dependent pathway, although evidence for a Trp-independent mechanism of IAA biosynthesis has also been reported [5, 6] . Apart from de novo synthesis, inactivation of the hormone also participates in the dynamic regulation of auxin metabolism, increasing the complexity of auxin homeostasis in cells. The two main routes of auxin inactivation are the conjugation of IAA to amino acids and sugars, and the oxidation of IAA to oxindole-3-acetic acid (oxIAA) [7, 8] . IAA conjugates are generally considered to be storage reserves of auxin as some of them can be hydrolyzed back to release free IAA [5] . IAA can be converted to amide conjugates by conjugation with amino acids by Group II members of the GRETCHEN HAGEN 3 (GH3) family of IAA-amide synthases [9, 10] . However, IAA conjugated with both aspartate (indole-3-acetyl-L-aspartic acid, IAAsp) and glutamate (indole-3-acetyl-L-Glutamic acid, IAGlu) are non-hydrolysable and their formation leads to an irreversible removal of IAA from the active pool [11, 12] . In addition, IAA can be reversibly conjugated via ester linkages to glucose by UDP-glucosyl transferases to produce indole-3-acetyl-1-glucosyl ester (IAGlc), where the Arabidopsis thaliana enzymes UGT84B1 and UGT74D1 are the strongest candidates [13] [14] [15] . The oxidative pathway is the major IAA catabolic pathway in Arabidopsis [12, 16, 17] and the irreversible formation of oxIAA was only recently ascribed to the activity of members of the 2-oxoglutaratedependent-Fe(II) dioxygenases, DIOXYGENASE FOR AUXIN OXIDATION (DAO) [18, 19] . oxIAA can be further conjugated to glucose by UGT74D1 in Arabidopsis, to produce oxindole-3-acetyl-1-glucosyl ester (oxIAGlc) [15] .
The identification of the different metabolic pathways has mainly been based on mutant analysis, metabolic profiling, in planta feeding assays, and measuring of enzyme activities in vitro. Metabolite feeding experiments have been carried out by supplying labeled IAA followed by mass spectrometry (MS) to identify de novo synthesized IAA catabolites and conjugates [12, 16, 18, 20, 21] . When Arabidopsis seedlings were fed with low concentrations of labeled auxin, IAA was mainly degraded to oxIAA and oxIAGlc, while higher levels of labeled IAA induced conjugation to IAAsp and IAGlu [12] . Similar metabolic analysis of dao1 loss-offunction mutant revealed that the reduction of IAA oxidation in this mutant did not change the levels of free IAA, whereas the IAA conjugates, IAAsp and IAGlu, accumulated at much higher levels in the dao1 mutant than in wild type seedlings [18] . These findings provide evidence to support the idea that DAOand GH3-mediated catabolic pathways influence each other's activities to maintain auxin homeostasis [22] . The functional characterization of GH3, UGT and DAO proteins in planta can be challenging due to large families and functional redundancy. Therefore, in vitro assays have previously been conducted with recombinant proteins in order to elucidate the molecular function of GH3, UGT and DAO enzymes during IAA inactivation [9, [13] [14] [15] 19, 23] .
GH3 enzymatic activity with various amino acid substrates has been examined using High Performance Liquid Chromatography (HPLC)-and thin-layer chromatography (TLC)-based assay methods in Arabidopsis [9] and in other plant species [24, 25] . Results from these studies have demonstrated that each GH3 enzyme has slightly different substrate specificity and probably contributes to the formation of several types of IAA-amino acid conjugates. Nonetheless, in vitro assays have revealed IAAsp to be a major conjugate formed by GH3.6, and that GH3.17 appears to favor glutamate over aspartate [9] . More recently, the development of a LC-MS-based assay allowed a steady-state kinetic analysis of several rice GH3 enzymes [26] [27] [28] . Several studies have shown that recombinant Arabidopsis UGT84B1 and UGT74D1 proteins catalyze the glucosylation of oxIAA and IAA to their corresponding glucosides in vitro [13] [14] [15] 23] . Moreover, recombinant UGT74D1 protein demonstrated to have a strong glucosylation activity towards various auxin-related compounds, but its activity is stronger with oxIAA than with IAA as a substrate [15] .
IAA conjugates and oxIAA are also predominant IAA metabolites, not only in other Viridiplantae, such as bryophytes [29] and algae, but also in cyanobacteria [30] , indicating that the mechanisms of IAA inactivation occurred very early during evolution [8] .
The in vitro enzyme assays are usually based on heterologous expression of plant genes in bacteria or yeast, followed by recombinant protein purification. This procedure can be very time-consuming and needs specific equipment and reagents to purify proteins on a large scale. Furthermore, the solubility and stability of the protein of interest can be problematic and lead to either poor yield or inactivation of the protein.
Here we introduce a reliable method for rapidly screening the activity of IAA conjugation and oxidation enzymes where the reactions have been performed directly in bacteria using recombinant proteins (Fig. 1a ). This method allows the detection and quantification of enzyme products without any purification step, after direct injection of a small supernatant fraction of the bacterial liquid culture, using ultrahigh-performance chromatography coupled to electrospray ionization tandem spectrometry (UHPLC-ESI-MS/MS). Our analysis shows that the products of interest were more abundant in the supernatant than in the pellet. The combination of these methods creates a faster, more reproducible and cheaper alternative to detect IAA catabolic products compared to the methods adopted so far. The proposed method provides a powerful alternative to screening orthologous candidate genes from non-model species, which is an important challenge due to the exponential increase of the sequenced genomes.
Methods
Cloning and protein expression of AtDAO1, AtGH3.6, AtGH3.17, AtUGT84B1
and AtUGT74D1
Full-length cDNAs of AtDAO1 (At1g14130), AtGH3.6 (At5g54510), AtGH3.17 (At1g28130), AtUGT84B1 (At2g23260) and AtUGT74D1 (At2g31750) were amplified with gene-specific primers containing additional XbaI and HindIII and NheI sites (Additional File 1: Table S1 ) using Arabidopsis cDNA as template. The cDNA fragments were cloned into the XbaI and HindIII or NheI restriction sites of a pETM-11 vector to generate recombinant fusion proteins with an N-terminal 6x His tag. The constructs were transformed into Escherichia coli BL21 (DE3). An E. coli strain carrying the pETM-11 vector containing the GFP coding sequence was used as control. For protein expression, E. coli containing the plasmids were grown in shaker flasks (250 rpm at 37°C) containing Luria Broth supplemented with 50 µg/ml (w/v) kanamycin to OD600 between 0.4 and 0.6. The production of recombinant proteins was induced by the addition of 0.1 mM isopropyl-β-Dthiogalactopyranoside (IPTG). To monitor the correct protein induction, cells were grown for 6 hours after IPTG induction at 20°C with constant shaking at 250 rpm and bacterial cultures were harvested for SDS/PAGE and Western blot analysis.
SDS/PAGE and Western blot analysis
To verify the induction of recombinant proteins, 2 ml of bacterial culture were harvested before and 6 hours after IPTG induction; cells were pelleted by centrifugation at 4000 rpm for 5 minutes. The pellet was washed and resuspended with 1 ml 1x PBS buffer (1 mM KH2PO4, 10 mM NaHPO4, 137 mM NaCl, 2.7 mM KCl) and cells lysed by sonication. Cell debris was pelleted by centrifugation (14000 rpm, 30 minutes, 4°C) and the supernatant was collected.
Ten µl of 4x Laemmli sample buffer (Biorad) was added to 30 µl of supernatant and denatured by boiling at 95°C for 5 minutes. Samples were then loaded on a 12% (w/v) SDS/PAGE gel and, after gel run, transferred to a PVDF membrane by wet electroblotting. For detection of recombinant proteins, the PVDF membrane was blocked in 1x TBS-T with 5% skimmed milk for 2 hours at room temperature. After blocking, the membrane was incubated with anti-6x His antibody horseradish peroxidase (HRP) conjugate (Sigma A7058-1VL, 1:10000 dilution in 1x TBS-T with 5% skimmed milk) for 2 hours at room temperature and washed for 10 minutes, four times, in 1x TBS-T. Signals were detected by an enhanced chemiluminescent (ECL) detection system (GE Healthcare RPN2232). ECL signals were captured by a charge-coupled device (CCD) camera (Azure c600) (Additional File 2: Figure S1 ).
Enzyme assay
To test the enzymatic activity of recombinant proteins, over-night induced bacterial cultures were supplemented with substrate in the culture medium. For AtDAO1, a culture of AtDAO1-expressing bacteria was supplemented with 0, 0.001, 0.01, or 0.1 mM IAA and with or without DAO cofactor mixture [5 mM 2oxoglutarate, 5 mM ascorbate, 0.5 mM (NH4)2Fe(SO4)2]. For the first trial, 1 ml samples were taken before (at time 0, T0) and after over-night incubation at 20°C with or without 0.001 mM IAA and with or without DAO cofactor mixture, centrifuged to pellet (4000 rpm for 5 minutes) and the resulting supernatant and pellet fractions were stored at -20°C and analyzed for oxIAA production by UHPLC-ESI-MS/MS as described below. The following experiments were carried out by analyzing only the supernatant fraction. Subsequently, the AtDAO1expressing bacterial culture was treated with or without 0.01 mM IAA, with or without the DAO cofactor mixture and kept at 20°C or 30°C. Samples were taken at 1 and 6 hours after incubation. Samples from GFP-expressing bacterial cultures and media without bacteria were used as negative controls. For AtGH3s, cultures of AtGH3.6-or AtGH3.17-expressing bacteria were kept at 20°C and treated with or without 0.1 mM IAA and with GH3 cofactor mixture (1 mM Glutamic acid, 1 mM Aspartic acid, 3 mM ATP, 3 mM MgCl2). Samples from GFPexpressing bacterial cultures were used as negative controls. Samples were collected 6 hours after incubation. For AtUGTs, cultures of AtUGT84B1-or AtUGT74D1-expressing bacteria were kept at 20°C and treated with or without 0.1 mM IAA and/or oxIAA and with UGT cofactor mixture (1 mM UDP-glucose, 2.5 mM MgSO4, 10 mM KCl). Samples were collected 6 hours after incubation.
Samples from GFP-expressing bacterial cultures were used as negative controls.
All the experiments were carried out with shaking at 250 rpm in the dark and repeated in triplicate.
UHPLC-ESI-MS/MS analysis
Supernatant fractions from bacterial cultures were analyzed according to the UHPLC-ESI-MS/MS method for auxin metabolic profiling described in [17, 31] , with modifications. The fractions were mixed using a vortex, and 2 μl per sample were transferred in insert-equipped vials and spiked with 5 μl of a 13 
Results and discussion

Optimization and validation of bacterial assay with AtDAO1
To optimize and validate the proposed method, we used E. coli cultures expressing recombinant AtDAO1 to test the effect of different experimental conditions on oxIAA production. AtDAO1 catalyzes the oxidation of IAA ( Fig. 1b) and this reaction represents the most important mechanism for IAA inactivation in plants [18, 21, 29, 30] . Recombinant AtDAO1 was expressed in bacterial cultures as an N-terminally tagged hexahistidine fusion protein and its expression was confirmed by Western blot analysis (Additional File 2: Figure   S1 ). In the first experiment, the enzymatic activity of recombinant AtDAO1 was tested by supplementing bacterial cultures expressing AtDAO1 with 0.001 mM IAA and measuring the levels of oxIAA in the supernatant and in the pellet fractions separately by UHPLC-ESI-MS/MS. Previous work has shown that the in vitro catalytic activity of recombinant DAO proteins [19, 32] requires, in addition to the substrate IAA, the co-substrate 2-oxoglutarate, and the cofactors (NH4)2Fe(SO4)2 and ascorbate in the reaction mixture. We therefore carried out, the assay by adding IAA to the bacterial cultures with or without a mixture containing co-substrate and cofactors (DAO cofactor mixture). Bacterial cultures expressing the GFP protein supplemented with IAA in the presence or absence of the DAO cofactor mixture were used as negative controls. Untreated bacterial cultures were used as mock samples. Bacterial cultures were sampled prior to the treatment with IAA (T0) and after over-night incubation at 20°C with the substrate, and with or without the DAO cofactor mixture. Under these conditions, the supernatant fraction exhibited a strong accumulation of oxIAA in all the samples compared with the pellet (Fig. 2a ). Our analysis shows the concentration of oxIAA to be higher in the culture media of bacterial cells transformed with AtDAO1 that were simultaneously incubated with IAA and DAO cofactor mixture than in the samples taken from the same bacterial culture that was treated with IAA alone (Fig. 2a ). However, background levels of oxIAA were observed in the culture media of AtDAO1-expressing bacteria that were not treated with IAA (mock), prior treatment (T0) and in all GFP samples ( Fig. 2a ). Low levels of IAA were detected in culture media before treatment with exogenous IAA (Additional File 4: Figure S2 ). Moreover, the basal accumulation of oxIAA that we observed in bacterial cultures could have been derived from the spontaneous non-enzymatic conversion of IAA into oxIAA, as has previously been reported in control samples from in vitro AtDAO assays [19] . Our results showed that AtDAO1 activity could be monitored by direct analysis of the levels of oxIAA that accumulate in the supernatant fraction of the AtDAO1-expressing bacterial cultures that had been supplemented simultaneously with low levels of exogenous IAA and DAO cofactor mixture. Therefore, in all further tests only the supernatant fractions were analyzed.
In the following experiment, we investigated the effect of temperature and exposure time to exogenous IAA and the DAO cofactor mixture on AtDAO1mediated oxIAA production. In previous studies, in vitro DAO assays were performed by incubating the reaction mixture containing the purified recombinant DAOs at 30°C for 1 hour [19, 32] . We therefore carried out an experiment in which AtDAO1-and GFP-expressing bacterial cultures were incubated at 20°C or 30°C with IAA and in the presence or absence of the DAO cofactor mixture. Samples were taken after 1 or 6 hours of treatment with IAA.
To reduce the impact of the natural non-enzymatic oxidation of IAA on the overall oxIAA production, bacterial cultures were treated with a higher concentration of IAA (0.01 mM) than that adopted in the initial experiment (0.001 mM). Untreated bacterial cultures were used as mock samples and culture media that had not been inoculated with bacteria (designed 'no bacteria') were sampled and analyzed as an additional control to monitor the background oxIAA formation that derives from the naturally occurring oxidation of IAA. We observed a very strong accumulation of oxIAA in AtDAO1 samples taken from cultures that were treated with IAA and the DAO cofactor mixture, compared with AtDAO1 from samples treated with IAA only (Fig. 2b) , indicating that the simultaneous supplementation of the DAO cofactor mixture and a higher concentration of IAA significantly enhanced AtDAO1-mediated oxIAA production.
This finding was also confirmed when AtDAO1-expressing bacterial cultures were incubated with 0.1 mM IAA (Fig. 3a) . The concentration of oxIAA was higher in AtDAO1 samples after prolonged treatment (6 hours) with substrate and the DAO cofactor mixture, than in samples that had a shorter exposure time (1 hour) (Fig. 2b) . Furthermore, oxIAA levels were slightly higher in the samples that were incubated at 20°C compared with samples from cultures kept at 30°C ( Fig. 2b ). No differences in oxIAA levels were detected among any GFP samples, any 'no bacteria' samples, nor any mock AtDAO1 samples ( Fig. 2b ), suggesting that low levels of non-enzymatic oxidation of IAA occurs in the culture media.
Together, these results suggest that incubation with the substrate and the DAO cofactor mixture for 6 hours at 20°C provides the optimal conditions for accumulating enzymatic product. These experimental settings were therefore adopted to develop the method further in later experiments with other enzymes involved in IAA inactivation; only GFP samples were included in the next experiments as a negative control.
IAA-conjugating activity of AtGH3.6, AtGH3.17, AtUGT84B1 and AtUGT74D1 in bacterial assay
Earlier work has demonstrated that Group II members of the GH3 family convert IAA into IAA-amino acids [9] . Some of the IAA-amino acid conjugates, such as IAAsp and IAGlu, are the most abundant in Arabidopsis [17] and are believed to be irreversible conjugates that cannot be hydrolyzed to form free IAA [12] .
Staswick et al. [9] tested the in vitro activity of several recombinant Arabidopsis GH3 proteins and carried out a screening of amino acid preferences using a TLCbased assay by which it was shown that AtGH3.17 prefers Glu over other amino acids, whereas AtGH3.6 exhibits activity with Asp. We therefore examined whether AtGH3.6 and AtGH3.17 could also catalyze the same reaction ( Fig. 1b) directly in bacterial cultures that express these recombinant proteins. AtGH3.6
and AtGH3.17 genes were expressed in E. coli individually and the expression of recombinant fusion proteins was confirmed by Western blot analysis (Additional File 2: Figure S1 ). Cultures of AtGH3.6-and AtGH3.17-expressing bacteria were tested in a reaction with or without 0.1 mM IAA in combination with the GH3 cofactor mixture (containing as co-substrates, aspartic and glutamic acid, and as cofactors, ATP and MgCl2) to determine whether IAAsp and/or IAGlu were formed. Figure 3b shows that the reaction mediated by AtGH3.6 yielded the accumulation of both IAA-amino acid conjugates, IAAsp and IAGlu, which is consistent with previous results reported by Staswick et al. [9] . Interestingly, AtGH3.6 preferred Glu over Asp since IAGlu concentration was higher than IAAsp under our experimental conditions (Fig. 3b ). Bacterial cultures expressing AtGH3.17 that were treated with IAA and the GH3 cofactor mixture accumulated very high levels of IAGlu while almost no IAAsp was detected (Fig. 3c IAGlc in vitro (Fig. 1b) [13, 14] . To investigate if AtUGT84B1 and AtUGT74D1 could catalyze the glucosylation of IAA in our experimental conditions, we expressed these two genes in E. coli individually and confirmed the expression of recombinant fusion proteins by Western blot analysis (Additional File 2: Figure   S1 ). Next, we treated bacterial cultures with or without 0.1 mM IAA in combination with the UGT cofactor mixture (containing as co-substrate, UDPG, and as cofactors, MgSO4 and KCl) and measured IAGlc levels. IAGlc accumulated in samples taken from cultures of bacteria transformed with either AtUGT84B1 or AtUGT74D1 that were treated with 0.1 mM IAA and UGT cofactor mixture, while IAGlc levels were below the limits of detection in samples taken from the same bacterial cultures that were not treated with IAA and UGT cofactor mixture ( Figs. 3d and 3e) . IAAsp, IAGlu and IAGlc levels were below the limits of detection in all GFP samples treated with IAA and cofactor mixtures, and in all mock GFP samples (Fig. 3f) . Taken together, these results demonstrate that AtGH3 and AtUGT proteins heterologously expressed in E. coli cells can efficiently conjugate IAA with amino acids and sugar, respectively, by performing the enzymatic assay with IAA and specific cofactor mixtures directly in bacterial cultures.
OxIAA-conjugating activity of AtUGT84B1 and AtUGT74D1 and competition assay
Conjugation of oxIAA with glucose to form oxIAGlc is an additional and relevant metabolic step in the oxIAA pathway. oxIAGlc, together with oxIAA, are the major degradation products of IAA in Arabidopsis [12, 17, 18] , suggesting that this reaction also contributes to IAA homeostasis. Previous studies have demonstrated that recombinant AtUGT74D1 protein converts not only IAA to IAGlc [14] , but also oxIAA to oxIAGlc (Fig. 1b) [15] . To verify whether recombinant AtUGT proteins exhibit glucosyl transferase activity towards oxIAA under our experimental conditions, we treated AtUGT84B1-and AtUGT74D1expressing bacterial cultures with 0.1 mM oxIAA in combination with the UGT cofactor mixture. oxIAGlc was detected in cultures that expressed AtUGT84B1 and AtUGT74D1, after treatment with oxIAA ( Figs. 4a and 4b) , indicating that these two AtUGTs can catalyze the glucosylation of oxIAA. To determine the substrate preference of these two AtUGTs, we performed a competition experiment in which cultures of AtUGT84B1-and AtUGT74D1-expressing bacteria were treated simultaneously with the same concentration of IAA and oxIAA and with the UGT cofactor mixture. When IAA and oxIAA competed with each other, IAA was found to be a better substrate as IAGlc levels were much higher than oxIAGlc in samples from both bacterial cultures expressing either of the two AtUGTs (Figs. 4a and 4b ). IAGlc and oxIAGlc were always below the limits of detection in GFP samples as well as in both AtUGTs mock samples (Fig.   4 ). Our finding is in contrast to that reported by Tanaka et al. [15] ; they showed that recombinant AtUGT74D1 had a higher specificity towards oxIAA than IAA in vitro. The discrepancy between these findings could be due to the different experimental conditions that were adopted to study the enzymatic activity.
Taken together, these results provide evidence that our method is suitable for testing different substrates by supplementing the compounds of interest, individually or simultaneously, directly in the bacterial cultures expressing the recombinant protein. In the present study, we were also able to show that AtUGT84B1 can catalyze not only the glucosylation of IAA but also of oxIAA to their corresponding glucosides. To the best of our knowledge, this is the first report in which AtUGT84B1 glucosyl transferase activity has been tested and demonstrated toward oxIAA.
Conclusions
The development of a rapid alternative method for screening heterologously expressed Arabidopsis enzymes involved in IAA inactivation is described. Our assays. The enzymatic method described here eliminates this technical constraint and represents a flexible system that is suitable for rapidly screening the activity of different hormone-modifying enzymes. It should be noted that, because it is impossible to quantify recombinant proteins directly in bacteria, at this stage our method cannot guarantee a precise kinetics of the enzymes.
Instead, the method proposed here provides an easy but powerful alternative to screen any putative orthologous genes from non-model species, allowing the characterization of genes from the newly sequenced genomes. As such it could be used to test for enzyme affinity toward different substrates, such as natural and synthetic molecules. However, due to its versatility, our method could also be adopted for testing specific enzyme inhibitors, such as compounds that are of interest in agriculture and horticulture. 
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